Western Australian Consolidated Regulations Western Australian Consolidated Regulations (1) The CEO may
approve a system of electronic prescribing if satisfied that the
system —
(a) is
sufficiently secure; and
(b) is
designed so that, to the extent practicable —
(i)
for any particular poison — only persons
authorised to prescribe that poison can use the system to prescribe the
poison; and
(ii)
for any particular poison — only a
pharmaceutical chemist authorised to dispense the poison, or an assistant
under the direct personal supervision of the pharmaceutical chemist, can use
the system to dispense the poison; and
(iii)
a poison dispensed in accordance with a prescription
issued via the system is dispensed for the person for whom it was prescribed;
and
(iv)
a poison dispensed to a person in accordance with a
prescription issued via the system is the poison prescribed for the person;
and
(c)
complies substantially with the criteria in Appendix K; and
(d)
complies with any other criteria the CEO thinks relevant.
(2) A reference in
subregulation (1)(b) to a person authorised to prescribe or dispense a
particular poison is a reference to a person authorised to do so under
the Act.
(3) Before being
satisfied that a system of electronic prescribing is sufficiently secure, the
CEO must be satisfied that, to the extent practicable —
(a)
personal information relating to prescribers, patients of prescribers and
pharmaceutical chemists is protected; and
(b)
access to and use of the system is controlled by appropriate procedures; and
(c) only
persons permitted to have access to the system according to those procedures
can have access to the system; and
(d)
every occurrence of —
(i)
a prescription being issued or amended via the system;
and
(ii)
a poison being dispensed in accordance with a
prescription issued via the system,
is recorded by the
system in a way that cannot be amended or erased.
(4)
Subregulation (3) does not limit the matters that the CEO may take into
account for the purposes of subregulation (1)(a).
(5) The CEO may
approve a component of a system of electronic prescribing if satisfied as to
the matters in subregulation (1) in relation to the component, to the
extent relevant to the component.
[Regulation 32B inserted in Gazette 7 Nov
2008 p. 4806-7.]